LU83654A1 - Nouvelle composition pharmaceutique notamment a action anti-ischemique - Google Patents

Nouvelle composition pharmaceutique notamment a action anti-ischemique Download PDF

Info

Publication number
LU83654A1
LU83654A1 LU83654A LU83654A LU83654A1 LU 83654 A1 LU83654 A1 LU 83654A1 LU 83654 A LU83654 A LU 83654A LU 83654 A LU83654 A LU 83654A LU 83654 A1 LU83654 A1 LU 83654A1
Authority
LU
Luxembourg
Prior art keywords
piperazine
benzyl
patients
day
treatment
Prior art date
Application number
LU83654A
Other languages
English (en)
French (fr)
Inventor
Michelle Devissaguet
Jean C Arnaud
Original Assignee
Science Union & Cie
Medicale Rech France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9246419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU83654(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Science Union & Cie, Medicale Rech France filed Critical Science Union & Cie
Publication of LU83654A1 publication Critical patent/LU83654A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LU83654A 1980-09-30 1981-09-28 Nouvelle composition pharmaceutique notamment a action anti-ischemique LU83654A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8020919 1980-09-30
FR8020919A FR2490963B1 (fr) 1980-09-30 1980-09-30 Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine

Publications (1)

Publication Number Publication Date
LU83654A1 true LU83654A1 (fr) 1982-04-14

Family

ID=9246419

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83654A LU83654A1 (fr) 1980-09-30 1981-09-28 Nouvelle composition pharmaceutique notamment a action anti-ischemique

Country Status (14)

Country Link
US (1) US4407801A (cg-RX-API-DMAC7.html)
AU (1) AU550761B2 (cg-RX-API-DMAC7.html)
BE (1) BE890568A (cg-RX-API-DMAC7.html)
CA (1) CA1169775A (cg-RX-API-DMAC7.html)
CH (1) CH650675A5 (cg-RX-API-DMAC7.html)
DE (1) DE3139005A1 (cg-RX-API-DMAC7.html)
FR (1) FR2490963B1 (cg-RX-API-DMAC7.html)
GB (1) GB2084019B (cg-RX-API-DMAC7.html)
GR (1) GR75803B (cg-RX-API-DMAC7.html)
IE (1) IE51764B1 (cg-RX-API-DMAC7.html)
IT (1) IT1171557B (cg-RX-API-DMAC7.html)
LU (1) LU83654A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ198435A (cg-RX-API-DMAC7.html)
ZA (1) ZA816766B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448776A (en) * 1981-02-12 1984-05-15 Karl Bucher Method of using certain substituted aliphatic secondary amines or their salts for easing breathing
SE8403912D0 (sv) * 1984-07-30 1984-07-30 Pharmacia Ab Lekemedelssats eller -komposition
FR2717687B1 (fr) * 1994-03-24 1996-06-14 Adir Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.
EP1104673A1 (en) * 1999-11-30 2001-06-06 Bayer Classics A hydrogen carbonate-containing, desintegrating agent-free pharmaceutical composition
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
FR2805463B1 (fr) * 2000-02-25 2003-01-24 Adir UTILISATION DE LA TRIMETAZIDINE POUR L'OBTENTION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES A INHIBER L'ACYL-CoA ACETYLTRANSFERASE
FR2818549B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine
WO2007116243A2 (en) * 2006-04-10 2007-10-18 Mintails Limited Method for treating fibromyalgia and related conditions
EA009776B1 (ru) * 2006-07-18 2008-04-28 Мераб Ревазович Кокеладзе Способ изготовления таблетированной лекарственной формы триметазидина дигидрохлорида и ее состав
FR2986431B1 (fr) * 2012-02-03 2017-03-17 Servier Lab Composition pharmaceutique a liberation prolongee de trimetazidine, son procede de fabrication et son utilisation dans des traitements therapeutiques
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
CN105055352A (zh) * 2015-08-11 2015-11-18 瑞阳制药有限公司 盐酸曲美他嗪片及其制备方法
US11123345B2 (en) * 2016-11-21 2021-09-21 Saghmos Therapeutics, Inc. Prevention and/or treatment of contrast-induced acute kidney injury
CN107982231B (zh) * 2018-01-03 2021-05-07 江苏吴中医药集团有限公司 一种盐酸曲美他嗪片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3262852A (en) * 1966-07-26 Vasodilator and anti-anginose com- pounds containing methoxy benzyl piperazines and method of using the same
FR805M (cg-RX-API-DMAC7.html) * 1960-06-30 1961-09-01

Also Published As

Publication number Publication date
CH650675A5 (fr) 1985-08-15
IT8149377A1 (it) 1983-03-28
CA1169775A (fr) 1984-06-26
FR2490963A1 (fr) 1982-04-02
BE890568A (fr) 1982-03-30
GB2084019B (en) 1984-09-12
IE812256L (en) 1982-03-30
IE51764B1 (en) 1987-03-18
IT1171557B (it) 1987-06-10
GB2084019A (en) 1982-04-07
ZA816766B (en) 1982-09-29
DE3139005A1 (de) 1982-05-06
FR2490963B1 (fr) 1986-04-18
IT8149377A0 (it) 1981-09-28
AU7574481A (en) 1982-04-08
AU550761B2 (en) 1986-04-10
GR75803B (cg-RX-API-DMAC7.html) 1984-08-02
US4407801A (en) 1983-10-04
NZ198435A (en) 1984-02-03

Similar Documents

Publication Publication Date Title
LU83654A1 (fr) Nouvelle composition pharmaceutique notamment a action anti-ischemique
RU2720204C1 (ru) Сублингвальная фармацевтическая композиция эдаравона и (+)-2-борнеола
KR20250026419A (ko) 글리부리드 및 다른 약물의 정맥내 투여를 위한 방법
PT2043637E (pt) Métodos e medicamentos para administração de ibuprofeno
EP3527203A1 (en) Oral dissolvable film of tadalafil and preparation method therefor
US20240024289A1 (en) Treatment of bipolar disorders and psychosis using dexmedetomidine hydrochloride
JP2024133735A (ja) Ｉｖ型コラーゲン疾患の処置のためのビフェニルスルホンアミド化合物
JP2018508479A (ja) 虚血性脳卒中を予防・治療するための薬物の調製におけるビフェノールの使用
EP0016890A1 (fr) Nouvelle forme galénique d'administration de la bêtahistine
Tamaki et al. Effects of lomerizine, a calcium channel antagonist, on retinal and optic nerve head circulation in rabbits and humans
CA2569537A1 (fr) Utilisation de la betaine pour le traitement des arterites
WO2001051033A1 (fr) Compositions pharmaceutiques solides pour la liberation controlee de substances actives
EP0063973A1 (fr) Composition pour collyre à base de sulfate de chondroitine A
EP3377061B1 (fr) Mirabégron pour le traitement de maladies rétiniennes
HU214719B (hu) Eljárás retinális betegségek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
JP2015512919A (ja) 塩酸レルカニジピンおよびロサルタンカリウム配合剤およびその調製法
US11980686B1 (en) Agomelatine oral transmucosal film
US20070231273A1 (en) Method for Decreasing Blood Glucose Levels
Mouly et al. Pharmacodynamics of a new ophthalmic mydriatic insert in healthy volunteers: potential alternative as drug delivery system prior to cataract surgery
EP0413694B1 (fr) Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur
RU2381034C1 (ru) Фармацевтическая композиция для лечения сосудистых осложнений диабета и диабетической полинейропатии
CA2376909A1 (fr) Medicaments ophtalmologiques neuro-et retino-protecteurs
JP2004331502A (ja) 視神経細胞保護剤
EP3331517B1 (fr) Utilisation d'hydroxycarbamide pour prevenir la non-perfusion retinienne
TWI781073B (zh) 正丁烯基苯酞的醫藥用途